These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6926836)

  • 21. Pharmacokinetics of hydralazine, apparent hydralazine and hydralazine pyruvic acid hydrazone in humans.
    Shepherd AM; Ludden TM; Haegele KD; Talseth T; McNay JL
    Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):129-44. PubMed ID: 515498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, Voltaren vs inflaban: effect of food on inflaban bioavailability.
    Zmeili S; Hasan M; Najib N; Sallam E; Deleq S; Shubair M
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):564-70. PubMed ID: 8996854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppressive treatment policies. A) Glucocorticoids: absorption of prednisolone. I. The effect of fasting, food, and food combined with antacids.
    Bergrem H; Djøseland O; Jervell J; Rugstad HE
    Scand J Urol Nephrol Suppl; 1981; 64():167-73. PubMed ID: 6959258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of food and of age on nitrazepam kinetics.
    Holm V; Melander A; Wåhlin-Boll E
    Drug Nutr Interact; 1982; 1(4):307-11. PubMed ID: 6926838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO; Mellstrand T; Svedmyr N
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetics and relative bioavailability of KC-404 sustained release tablets in healthy volunteers].
    Li T; Pang Y; Wang Z; Jia Y; Cheng Q; Sun J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):541-3. PubMed ID: 12910715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers.
    Zhao Q; Janssens L; Verhaeghe T; Brashear HR; Truyen L
    Curr Med Res Opin; 2005 Oct; 21(10):1547-54. PubMed ID: 16238894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Food interaction pharmacokinetic study of cordaflex 20 mg retard filmtablet in healthy volunteers.
    Balogh Nemes K; Horváth V; Grézal G; Horvai G; Hrabéczy-Páll A; Kocsi E; Drabant S; Csörgö M; Renczes G; Klebovich I
    Int J Clin Pharmacol Ther; 1998 May; 36(5):263-9. PubMed ID: 9629990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of food on oral availability of apresoline and controlled release hydralazine in hypertensive patients.
    Jackson SH; Shepherd AM; Ludden TM; Jamieson MJ; Woodworth J; Rogers D; Ludden LK; Muir KT
    J Cardiovasc Pharmacol; 1990 Oct; 16(4):624-8. PubMed ID: 1706804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absorption of theophylline from conventional and sustained-release tablets.
    Mellstrand T; Svedmyr N; Fagerström PO
    Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of doses on the bioavailability of phenytoin from a prompt-release and an extended-release preparation: single dose study.
    Rojanasthien N; Chaichana N; Teekachunhatean S; Kumsorn B; Sangdee C; Chankrachang S
    J Med Assoc Thai; 2007 Sep; 90(9):1883-93. PubMed ID: 17957935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioavailability of standard and sugar-coated hydrallazine formulations in fast and slow acetylators [proceedings].
    Hawksworth GM; Morrice M; Petrie JC; Scott AK
    Br J Clin Pharmacol; 1980 Jan; 9(1):111P-112P. PubMed ID: 7356875
    [No Abstract]   [Full Text] [Related]  

  • 33. Bioavailability of modified-release methylphenidate: influence of high-fat breakfast when administered intact and when capsule content sprinkled on applesauce.
    Lee L; Kepple J; Wang Y; Freestone S; Bakhtiar R; Wang Y; Hossain M
    Biopharm Drug Dispos; 2003 Sep; 24(6):233-43. PubMed ID: 12973820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the intragastric location of extended release tablets on food interactions.
    Weitschies W; Wedemeyer RS; Kosch O; Fach K; Nagel S; Söderlind E; Trahms L; Abrahamsson B; Mönnikes H
    J Control Release; 2005 Nov; 108(2-3):375-85. PubMed ID: 16213057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absolute bioavailability and absorption characteristics of divalproex sodium extended-release tablets in healthy volunteers.
    Dutta S; Reed RC; Cavanaugh JH
    J Clin Pharmacol; 2004 Jul; 44(7):737-42. PubMed ID: 15199078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydralazine slow-release: observations on serum profile and clinical efficacy in man.
    Talseth T; Fauchald P; Pape JF
    Curr Ther Res Clin Exp; 1977 Feb; 21(2):157-68. PubMed ID: 403050
    [No Abstract]   [Full Text] [Related]  

  • 37. A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions.
    Guivarc'h PH; Vachon MG; Fordyce D
    Clin Ther; 2004 Sep; 26(9):1456-69. PubMed ID: 15531008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative bioavailability of griseofulvin lyophilized dry emulsion tablet vs. immediate release tablet: a single-dose, randomized, open-label, six-period, crossover study in healthy adult volunteers in the fasted and fed states.
    Ahmed IS; Aboul-Einien MH; Mohamed OH; Farid SF
    Eur J Pharm Sci; 2008 Oct; 35(3):219-25. PubMed ID: 18675344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the effect of different kinds of foods on the bioavailability of a sustained-release theophylline tablet.
    Gai MN; Thielemann AM; Arancibia A
    Int J Clin Pharmacol Ther Toxicol; 1993 Nov; 31(11):547-52. PubMed ID: 8294167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The bioavailability of enteric coated diclofenac formulations. 2. Bioavailability following single administration of a multiple-unit formulation in comparison to a single-unit formulation under fasting and non-fasting conditions].
    Scheidel B; Blume H; Walter K; Stanislaus F; Babej-Dölle RM
    Arzneimittelforschung; 1994 Apr; 44(4):544-50. PubMed ID: 8011009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.